We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




PCR Technology Helps Detect Food Pathogens and Spoilage Microorganisms

By Labmedica staff writers
Posted on 28 Apr 2008
Advanced real-time polymerase chain reaction (PCR) technology is increasingly being used in the rapid detection of food pathogens and spoilage microorganisms. More...
The technique allows an exponential amplification of DNA from just a few to more than a billion copies in less than one hour. This enables a significant reduction in the time taken to achieve results in comparison with conventional cultivation techniques.

The increasing use of rapid food safety testing is receiving more and more attention. The major reason for this key trend is that the food industry requires quick and accurate results. Traditional microbiological methods are relatively slow and sometimes inaccurate in comparison to new molecular biologic techniques. Fast and reliable detection systems are therefore the method of choice.

Under its foodproof brand, Biotecon Diagnostics (Potsdam, Germany) has developed real-time PCR detection kits for Enterobacteriaceae plus Enterobacter sakazakii (new), Salmonella, Listeria, Campylobacter, Escherichia coli O157, among others. The range also comprises a unique kit for the screening of beer spoilage organisms as well as genetically modified organism (GMO) testing kits.

To enhance the worldwide launch of its food safety testing systems, Biotecon Diagnostics has formed a strategic marketing alliance with the globally operating Merck (Darmstadt, Germany). Merck sells the foodproof range that has been available in almost all countries of the world since January 1, 2008. More products are expected to be forthcoming later in the year.

Dr. Kornelia Berghof-Jaeger, CEO, Biotecon Diagnostics said, "In this alliance, Merck KGaA will contribute significantly through its expertise in microbiology and its excellent customer relationships. Jointly we are able to fulfill the customer needs by introducing this new technology to the food safety testing labs around the world.”

"For Merck KGaA, this partnership means a consequential advancement in order to underline our leading position in specialty chemicals, especially in analytical reagents and test kits,” commented Wolfgang E. Schmidt, head of microbiology, hygiene, and microscopy at Merck KGaA. "Our philosophy of highest quality demands is perfectly met by the solutions offered by Biotecon Diagnostics.”


Related Links:
Biotecon Diagnostics
Merck

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Modular Hemostasis Automation Solution
CN Track
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.